The cyclic dynorphin A analogue [N(alpha)-benzylTyr(1),cyclo(D-Asp(5),Dap(8))]dynorphin A-(1-11)NH(2) (Dap = 2,3-diaminopropionic acid) exhibits nanomolar affinity (30 nM) and high selectivity (K(i) ratio (kappa/mu/delta) = 1/194/330) for kappa-opioid receptors. This analogue antagonizes dynorphin A-(1-13)NH(2) at kappa-opioid receptors in the adenylyl cyclase assay (K(B) = 84 nM). This is the first dynorphin A-based antagonist with modifications in the C-terminal "address" domain that alter efficacy and thus represents a novel selective kappa-opioid receptor antagonist.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/jm050105i | DOI Listing |
Publication Analysis
Top Keywords
"address" domain
8
kappa-opioid receptor
8
receptor antagonist
8
kappa-opioid receptors
8
[nalpha-benzyltyr1cyclod-asp5dap8]- dynorphin
4
dynorphin a-1-11nh2
4
a-1-11nh2 cyclized
4
cyclized "address"
4
domain novel
4
kappa-opioid
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!